2 hours ago · China
China trial shows gum tissue stem cells help 55% of lifetime diabetes patients
What's happening
SignalsMonitor is following this as a general story. South China Morning Post Asia is the outlet attached so far. The reports are tied to China. The first report grouped here was at 27 Oct 2026, 06:00 UTC. The headline in use is “China trial shows gum tissue stem cells help 55% of lifetime diabetes patients”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
A randomised phase 1 clinical trial conducted by scientists and doctors from Shanghai and Guangzhou has achieved encouraging results in the treatment of Type 1 diabetes using stem cells extracted from the mouth’s gum tissue. More than half of those who received the treatment showed varying degrees of improvement, while…
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by South China Morning Post Asia
China trial shows gum tissue stem cells help 55% of lifetime diabetes patients
Reported by 1 outlet
- South China Morning Post
- South China Morning PostChina trial shows gum tissue stem cells help 55% of lifetime diabetes patients